|
Volumn 165, Issue 10, 2002, Pages 1377-1383
|
Systemic effect comparisons of six inhaled corticosteroid preparations
a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h a,b,c,d,e,f,g,h |
Author keywords
Cortisol suppression; Inhaled corticosteroids; Systemic effects
|
Indexed keywords
BECLOMETASONE;
BUDESONIDE;
CHLOROFLUOROCARBON;
CORTICOSTEROID;
FLUNISOLIDE;
FLUTICASONE PROPIONATE;
HYDROCORTISONE;
OSTEOCALCIN;
PLACEBO;
TRIAMCINOLONE ACETONIDE;
ANDROSTANE DERIVATIVE;
DRUG DERIVATIVE;
FLUOCINOLONE ACETONIDE;
FLUTICASONE;
TRIAMCINOLONE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRY POWDER;
FEMALE;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
HYDROCORTISONE URINE LEVEL;
MAJOR CLINICAL STUDY;
MALE;
METERED DOSE INHALER;
MULTICENTER STUDY;
POWDER INHALER;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
TREATMENT OUTCOME;
AGED;
BLOOD;
COMPARATIVE STUDY;
DRUG ADMINISTRATION;
FOLLOW UP;
INHALATIONAL DRUG ADMINISTRATION;
MIDDLE AGED;
PROBABILITY;
REFERENCE VALUE;
ADMINISTRATION, INHALATION;
ADRENAL CORTEX HORMONES;
ADULT;
AGED;
ANDROSTADIENES;
ASTHMA;
BECLOMETHASONE;
BUDESONIDE;
COMPARATIVE STUDY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOCINOLONE ACETONIDE;
FOLLOW-UP STUDIES;
HUMAN;
HYDROCORTISONE;
MALE;
MIDDLE AGE;
PROBABILITY;
REFERENCE VALUES;
SINGLE-BLIND METHOD;
SUPPORT, U.S. GOV'T, P.H.S.;
TREATMENT OUTCOME;
TRIAMCINOLONE;
HUMANS;
MIDDLE AGED;
|
EID: 0037092558
PISSN: 1073449X
EISSN: None
Source Type: Journal
DOI: 10.1164/rccm.2105013 Document Type: Article |
Times cited : (233)
|
References (27)
|